Clinical Trials Logo

Stage IB Melanoma clinical trials

View clinical trials related to Stage IB Melanoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01898403 Active, not recruiting - Stage IV Melanoma Clinical Trials

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Start date: June 2013
Phase: N/A
Study type: Interventional

This clinical trial studies lymph node mapping using indocyanine green solution in diagnosing patients with malignant melanoma. Diagnostic procedures, such as lymph node mapping using indocyanine green solution, may help find out how far the melanoma has spread and may help in planning cancer treatment.

NCT ID: NCT01826864 Withdrawn - Stage IIC Melanoma Clinical Trials

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma

Start date: August 5, 2011
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies sargramostim before sentinel lymph node biopsy to see how well it works compared to hypertonic saline before sentinel lymph node biopsy in treating patients with melanoma. Biological therapies, such as sargramostim, may stimulate the immune system in different ways and stop cancer cells from growing. It is not yet known whether sargramostim is more effective than hypertonic saline in treating patients with stage IB-II melanoma undergoing sentinel lymph node biopsy.

NCT ID: NCT00003895 Completed - Recurrent Melanoma Clinical Trials

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

Start date: April 1999
Phase: Phase 2
Study type: Interventional

This randomized pilot phase II trial studies how well vaccine therapy works in treating human leukocyte antigen class 1 histocompatibility, A-2 (HLA-A2) positive patients with melanoma. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells.